Napabucasin prodrug

N/A

Report date: 2026/03/30 17:02:26

Base Information

Drug NameNapabucasin prodrug
Drug Alias NameDSP-0337
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionSignal transducer and activator of transcription 3 inhibitors
TargetsSignal transducer and activator of transcription 3
Therapy Area/IndicationsNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusDiscontinued (Phase 1 Clinical)
Highest Status in ChinaN/A
Originator CompaniesBoston Biomedical Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesSumitomo Pharma America Inc
Active IndicationsN/A
Inactive IndicationsNeoplasms

Other Information

ATC CodeN/A
Related LinksN/A